Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
40.05
+1.05 (2.69%)
At close: Sep 4, 2026, 4:00 PM EDT
40.50
+0.45 (1.12%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $1.03 billion as of September 4, 2026. Its market cap has increased by 9,352.95% in one year.
Market Cap
1.03B
Enterprise Value
849.06M
1-Year Change
9,352.95%
Ranking
Category
Stock Price
$40.05
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $1.03B, an increase of 85.25%. That is a compound annual growth rate of 11.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.03B | 7,589.94% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.11B |
| Solid Biosciences | 1.10B |
| Obsidian Therapeutics | 1.04B |
| Avalo Therapeutics | 1.03B |
| Arbutus Biopharma | 1.02B |
| Geron | 1.01B |
| Lexicon Pharmaceuticals | 996.70M |
| Immix Biopharma | 995.11M |